Sea Changes In Regulation And The Market: Top Stories Of 2008
This article was originally published in The Tan Sheet
Executive Summary
When an iconic drug brand drew scrutiny on Capitol Hill for possibly violating FDA's policy against combinations of drugs and dietary supplements, OTC and supplement interests took notice